Beam Therapeutics Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4Beam Therapeutics Inc.BEAM2d

   BEAM CEO Evans John M. sold shares

   • 10/15/2026: Sold 25,000 shares at $23.57
   • 10/16/2026: Sold 25,000 shares at $23.98
   • Exercised stock options for 25,000 shares at $1.03

   John M. Evans, reporting

2. ROUTINE144Beam Therapeutics Inc.BEAM2d

   BEAM THERAPEUTICS INC. files Form 144

   • Filer: Evans John M.
   • 25,000 shares to be sold
   • Aggregate market value: $599,595

   John M. Evans, reporting

3. ROUTINE144Beam Therapeutics Inc.BEAM3d

   BEAM THERAPEUTICS INC. files Form 144

   • Filer: Evans John M.
   • 25,000 shares to be sold
   • Aggregate market value: $589,150

   John M. Evans, reporting

4. ROUTINE4Beam Therapeutics Inc.BEAMOct 2

   Beam Therapeutics Inc. reports stock sale

   • 10/01/2026 - 187 shares sold
   • Price: $24.41
   • Covering tax obligations from restricted stock units

   Bethany J Cavanagh

5. ROUTINE4Beam Therapeutics Inc.BEAMSep 25

   Giuseppe Ciaramella, insider filing for BEAM

   Giuseppe Ciaramella, reporting

6. ROUTINESCHEDULE 13G/ABeam Therapeutics Inc.BEAMAug 14

   Ownership stake disclosure by ARK Investment Management LLC (amended)

   ARK Investment Management LLC, filed by

7. ROUTINESCHEDULE 13G/ABeam Therapeutics Inc.BEAMAug 13

   Ownership stake disclosure by FARALLON CAPITAL MANAGEMENT, L.L.C. (amended)

   FARALLON CAPITAL MANAGEMENT, L.L.C., filed by

8. NOTABLE10-QBeam Therapeutics Inc.BEAMAug 4

   Quarterly report

9. ROUTINE8-KBeam Therapeutics Inc.BEAMAug 4

   Current report

10. ROUTINE4Beam Therapeutics Inc.BEAMJul 29

    Amy Simon, insider filing for BEAM

    Amy Simon, reporting

11. ROUTINE144Beam Therapeutics Inc.BEAMJul 27

    Amy Simon, planned sale of BEAM shares

    Amy Simon, reporting

12. ROUTINE4Beam Therapeutics Inc.BEAMJul 2

    Amy Simon, insider filing for BEAM

    Amy Simon, reporting

13. ROUTINE4Beam Therapeutics Inc.BEAMJul 1

    John M. Evans, insider filing for BEAM

    John M. Evans, reporting

14. ROUTINE144Beam Therapeutics Inc.BEAMJun 30

    John M. Evans, planned sale of BEAM shares

    John M. Evans, reporting

15. ROUTINE144Beam Therapeutics Inc.BEAMJun 29

    John M. Evans, planned sale of BEAM shares

    John M. Evans, reporting

16. ROUTINE4Beam Therapeutics Inc.BEAMJun 29

    FMR LLC, insider filing for BEAM

    FMR LLC, reporting

17. ROUTINE4Beam Therapeutics Inc.BEAMJun 22

    Giuseppe Ciaramella, insider filing for BEAM

    Giuseppe Ciaramella, reporting

18. ROUTINE8-KBeam Therapeutics Inc.BEAMJun 8

    Current report

19. ROUTINE4Beam Therapeutics Inc.BEAMJun 5

    6 insider filings

    Graham K Cooper, insider filing for BEAM

    Show all 6

    • 4Insider filing for BEAMJun 5
    • 4Insider filing for BEAMJun 5
    • 4Insider filing for BEAMJun 5
    • 4Insider filing for BEAMJun 5
    • 4Insider filing for BEAMJun 5
    • 4Insider filing for BEAMJun 5

    Graham K Cooper, reporting

20. NOTABLE10-QBeam Therapeutics Inc.BEAMMay 7

    Quarterly report

21. ROUTINE8-KBeam Therapeutics Inc.BEAMMay 7

    Current report

22. ROUTINESCHEDULE 13GBeam Therapeutics Inc.BEAMApr 29

    Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC

    VANGUARD CAPITAL MANAGEMENT LLC, filed by

23. ROUTINEARSBeam Therapeutics Inc.BEAMApr 17

    Annual report to shareholders

24. ROUTINEDEFA14ABeam Therapeutics Inc.BEAMApr 17

    Additional proxy materials

25. ROUTINEDEF 14ABeam Therapeutics Inc.BEAMApr 17

    Proxy statement

26. ROUTINE144Beam Therapeutics Inc.BEAMApr 14

    Carole Ho, planned sale of BEAM shares

    Carole Ho, reporting

27. ROUTINE4Beam Therapeutics Inc.BEAMApr 6

    5 insider filings

    John M. Evans, insider filing for BEAM

    Show all 5

    • 4Insider filing for BEAMApr 6
    • 4Insider filing for BEAMApr 6
    • 4Insider filing for BEAMApr 6
    • 4Insider filing for BEAMApr 6
    • 4Insider filing for BEAMApr 6

    John M. Evans, reporting

28. ROUTINE4Beam Therapeutics Inc.BEAMApr 2

    5 insider filings

    Christine Bellon, insider filing for BEAM

    Show all 5

    • 4Insider filing for BEAMApr 2
    • 4Insider filing for BEAMApr 2
    • 4Insider filing for BEAMApr 2
    • 4Insider filing for BEAMApr 2
    • 4Insider filing for BEAMApr 2

    Christine Bellon, reporting

29. ROUTINE4Beam Therapeutics Inc.BEAMApr 1

    John M. Evans, insider filing for BEAM

    John M. Evans, reporting

30. ROUTINE144Beam Therapeutics Inc.BEAMMar 31

    5 Form 144 notices

    Christine Bellon, planned sale of BEAM shares

    Show all 5

    • 144Planned insider sale of BEAM sharesMar 31
    • 144Planned insider sale of BEAM sharesMar 31
    • 144Planned insider sale of BEAM sharesMar 31
    • 144Planned insider sale of BEAM sharesMar 31
    • 144Planned insider sale of BEAM sharesMar 31

    Christine Bellon, reporting

31. ROUTINE144Beam Therapeutics Inc.BEAMMar 30

    John M. Evans, planned sale of BEAM shares

    John M. Evans, reporting

32. ROUTINESCHEDULE 13G/ABeam Therapeutics Inc.BEAMMar 26

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

33. ROUTINE8-KBeam Therapeutics Inc.BEAMMar 5

    Current report

Older filings on EDGAR